$AMED
AMEDISYS INC

2015 Q2 Form 10-Q Financial Statement

#000119312515267794 Filed on July 29, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $314.2M $305.0M
YoY Change 3.02% -3.48%
Cost Of Revenue $175.7M $172.5M
YoY Change 1.84% -2.02%
Gross Profit $138.5M $132.5M
YoY Change 4.53% -4.12%
Gross Profit Margin 44.08% 43.44%
Selling, General & Admin $118.3M $112.2M
YoY Change 5.44% -8.26%
% of Gross Profit 85.42% 84.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.700M $7.700M
YoY Change -38.96% -19.79%
% of Gross Profit 3.39% 5.81%
Operating Expenses $122.9M $119.9M
YoY Change 2.5% -8.89%
Operating Profit $15.53M $12.56M
YoY Change 23.61% 231.16%
Interest Expense $2.416M $1.352M
YoY Change 78.7% 85.21%
% of Operating Profit 15.56% 10.76%
Other Income/Expense, Net $2.912M -$208.0K
YoY Change -1500.0% -287.39%
Pretax Income $18.44M $12.35M
YoY Change 49.27% 274.33%
Income Tax $7.566M $4.743M
% Of Pretax Income 41.03% 38.4%
Net Earnings $10.60M $7.600M
YoY Change 39.47% 322.22%
Net Earnings / Revenue 3.37% 2.49%
Basic Earnings Per Share $0.32 $0.24
Diluted Earnings Per Share $0.32 $0.23
COMMON SHARES
Basic Shares Outstanding 33.00M shares 32.25M shares
Diluted Shares Outstanding 33.46M shares 32.59M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.20M $11.20M
YoY Change 196.43% -62.79%
Cash & Equivalents $33.20M $11.23M
Short-Term Investments
Other Short-Term Assets $24.70M $36.80M
YoY Change -32.88% 36.3%
Inventory
Prepaid Expenses
Receivables $110.5M $110.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $168.4M $158.9M
YoY Change 5.98% -12.6%
LONG-TERM ASSETS
Property, Plant & Equipment $67.00M $148.3M
YoY Change -54.82% -5.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $171.3M $163.3M
YoY Change 4.9% 49.54%
Total Long-Term Assets $477.0M $551.4M
YoY Change -13.49% 6.35%
TOTAL ASSETS
Total Short-Term Assets $168.4M $158.9M
Total Long-Term Assets $477.0M $551.4M
Total Assets $645.4M $710.3M
YoY Change -9.14% 1.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.90M $18.90M
YoY Change 15.87% -12.9%
Accrued Expenses $138.8M $169.6M
YoY Change -18.16% 30.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $12.00M $12.30M
YoY Change -2.44% -65.64%
Total Short-Term Liabilities $176.0M $200.7M
YoY Change -12.31% 5.08%
LONG-TERM LIABILITIES
Long-Term Debt $83.50M $132.0M
YoY Change -36.74% 238.46%
Other Long-Term Liabilities $5.800M $6.500M
YoY Change -10.77% 25.0%
Total Long-Term Liabilities $83.50M $132.0M
YoY Change -36.74% 238.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $176.0M $200.7M
Total Long-Term Liabilities $83.50M $132.0M
Total Liabilities $266.1M $338.4M
YoY Change -21.37% 42.97%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $379.3M $371.9M
YoY Change
Total Liabilities & Shareholders Equity $645.4M $710.3M
YoY Change -9.14% 1.43%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income $10.60M $7.600M
YoY Change 39.47% 322.22%
Depreciation, Depletion And Amortization $4.700M $7.700M
YoY Change -38.96% -19.79%
Cash From Operating Activities $42.50M -$89.20M
YoY Change -147.65% -365.48%
INVESTING ACTIVITIES
Capital Expenditures -$14.60M -$3.600M
YoY Change 305.56% -62.11%
Acquisitions
YoY Change
Other Investing Activities $4.800M -$900.0K
YoY Change -633.33% -140.91%
Cash From Investing Activities -$9.700M -$4.500M
YoY Change 115.56% -39.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.700M 102.0M
YoY Change -102.65% -3390.32%
NET CHANGE
Cash From Operating Activities 42.50M -89.20M
Cash From Investing Activities -9.700M -4.500M
Cash From Financing Activities -2.700M 102.0M
Net Change In Cash 30.10M 8.300M
YoY Change 262.65% -64.07%
FREE CASH FLOW
Cash From Operating Activities $42.50M -$89.20M
Capital Expenditures -$14.60M -$3.600M
Free Cash Flow $57.10M -$85.60M
YoY Change -166.71% -298.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4593000
CY2014Q2 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
7692000
us-gaap Interest Expense
InterestExpense
2613000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6777000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1671000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2632000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
434000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-486000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
1026000
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
298625000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12353000
CY2015Q2 us-gaap Interest Expense
InterestExpense
2416000
CY2014Q2 us-gaap Interest Expense
InterestExpense
1352000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15527000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
12561000
CY2015Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2014Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
292445000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7566000
CY2015Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
4000
CY2014Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
16000
CY2015Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4826000
CY2014Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
885000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
498000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
243000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2912000
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-208000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18439000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4743000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
139804000
CY2015Q2 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
2756000
CY2014Q2 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
4242000
us-gaap Share Based Compensation
ShareBasedCompensation
1500000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
154571000
us-gaap Cost Of Services
CostOfServices
346660000
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2193000
us-gaap Cost Of Services
CostOfServices
349527000
CY2015Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
71249000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
5732000
CY2014Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
35522000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
75183000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
78222000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
9135000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
615724000
CY2014Q2 us-gaap Cost Of Services
CostOfServices
172520000
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1069000
us-gaap Share Based Compensation
ShareBasedCompensation
4577000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
11152000
CY2015Q2 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
4615000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
75193000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2208000
us-gaap Costs And Expenses
CostsAndExpenses
610757000
us-gaap Operating Income Loss
OperatingIncomeLoss
-42577000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7012000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
26000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
22000
us-gaap Interest Expense
InterestExpense
4842000
us-gaap Costs And Expenses
CostsAndExpenses
658301000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
15594000
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-216000
us-gaap Profit Loss
ProfitLoss
-4839000
CY2015Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
10637000
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
61000
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.32
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.23
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2014Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
7558000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4582000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-530000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-14788000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
553000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4638000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16861000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3849000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1160000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.14
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6163000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4189000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57037000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-37984000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7498000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14025000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2875000
CY2015Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
10873000
CY2014Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
7610000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-23959000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4623000
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
61000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2015Q2 us-gaap Profit Loss
ProfitLoss
10873000
CY2014Q2 us-gaap Profit Loss
ProfitLoss
7671000
us-gaap Profit Loss
ProfitLoss
-23959000
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
236000
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
52000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
413000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-41000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
10637000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
7619000
us-gaap Net Income Loss
NetIncomeLoss
-4798000
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.32
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.24
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.74
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.14
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
219600000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7627000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16668000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
19000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11822000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
195000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1059000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20046000
us-gaap Interest Paid
InterestPaid
3598000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2496000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1200000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
414000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5958000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9068000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95471000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9392000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
283000
us-gaap Interest Paid
InterestPaid
2974000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3017000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
67000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2688000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
88000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
5000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2215000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11225000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98785000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1324000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6078000
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
2600000
CY2014Q2 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
1800000
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.6 pure
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.5 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates</font></p><p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and </font><font style="font-family:Times New Roman;font-size:10pt;">reporting policies conform </font><font style="font-family:Times New Roman;font-size:10pt;">with</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">In preparing the </font><font style="font-family:Times New Roman;font-size:10pt;">unaudited </font><font style="font-family:Times New Roman;font-size:10pt;">condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</font></p>
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Reclassifications and Comparability </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain </font><font style="font-family:Times New Roman;font-size:10pt;">reclassifications have been made to prior periods' financial statements in order to conform to the current period'</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;"> presentation</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p>
CY2015Q2 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.50 pure
CY2015Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.80 pure
CY2014Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.82 pure
CY2015Q2 us-gaap Cost Method Investments
CostMethodInvestments
0
CY2015Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34 States
CY2014Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
18800000
CY2015Q2 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.20 pure
CY2015Q2 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
21700000
CY2014Q4 us-gaap Cost Method Investments
CostMethodInvestments
5000000
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.80 pure
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.82 pure
amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60
amed Episodes In Progress That Begin During Reporting Period
EpisodesInProgressThatBeginDuringReportingPeriod
60
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 Number_of_Visits
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 Number_of_Visits
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 Number_of_Visits
CY2015Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.10 pure
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 Number_of_Visits
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99 pure
CY2014Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1 pure
amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365
amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.66 pure
CY2014 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.69 pure
CY2015Q2 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
1100000
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
3000000
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60
CY2014Q4 us-gaap Land
Land
3200000
CY2014Q4 amed Buildingandleaseholdimprovements
Buildingandleaseholdimprovements
25300000
CY2014Q4 amed Equipmentandfurniture
Equipmentandfurniture
97200000
CY2014Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
158200000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
283900000
CY2015Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
91400000
CY2015Q2 amed Equipmentandfurniture
Equipmentandfurniture
96800000
CY2015Q2 us-gaap Land
Land
3200000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
216800000
CY2015Q2 amed Buildingandleaseholdimprovements
Buildingandleaseholdimprovements
25400000
CY2015Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
95500000
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
192000 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33459000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32871000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32058000 shares
CY2015Q2 amed Total Leverage Ratio
TotalLeverageRatio
1.0 pure
CY2015Q2 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
2.8 pure
CY2015Q2 amed Senior Secured Leverage Ratio
SeniorSecuredLeverageRatio
0.4 pure
CY2015Q2 amed Corporate Integrity Agreement Term
CorporateIntegrityAgreementTerm
P5Y
CY2014Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-400000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-200000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
-300000
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
900000
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segments
CY2015Q2 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
115600000
CY2014Q2 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
108000000
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
234300000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
116400000
CY2015Q2 us-gaap Long Term Debt
LongTermDebt
95500000
CY2015Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
83500000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
104400000

Files In Submission

Name View Source Status
0001193125-15-267794-index-headers.html Edgar Link pending
0001193125-15-267794-index.html Edgar Link pending
0001193125-15-267794.txt Edgar Link pending
0001193125-15-267794-xbrl.zip Edgar Link pending
amed-20150630.xml Edgar Link completed
amed-20150630.xsd Edgar Link pending
amed-20150630_cal.xml Edgar Link unprocessable
amed-20150630_def.xml Edgar Link unprocessable
amed-20150630_lab.xml Edgar Link unprocessable
amed-20150630_pre.xml Edgar Link unprocessable
d943972d10q.htm Edgar Link pending
d943972dex311.htm Edgar Link pending
d943972dex312.htm Edgar Link pending
d943972dex321.htm Edgar Link pending
d943972dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g943972img1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending